|
|
 |
|
Viewing report
|
|
|
|
Isis Pharmaceuticals, Inc.
MarketLine, Dec 2011, Pages: 44
Isis Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Isis Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Isis Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Isis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Isis Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Isis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:
Isis Pharmaceuticals (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. The company's principal activity is to develop and market RNA-based drugs for the treatment of cardiovascular diseases, metabolic, inflammatory and cancer diseases. The company primarily operates in the US. Isis is headquartered in Carlsbad, California and employed 270 people as of February 14, 2011. The company recorded revenues of $108.5 million during the financial year (FY) ended December 2010, a decrease of 10.8% over FY2009. The operating loss of the company was $48.4 million during FY2010, as compared with an operating loss of $27.5 million in FY2009. The net loss was $61.3 million in FY2010, as compared with a net profit of $155.1 million in FY2009.
Reasons to Purchase:
- Gain understanding of Isis Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Isis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Isis Pharmaceuticals, Inc.’s business structure, strategy and prospects
|
|
|
|
